Characteristics of study participants
| . | MBL . | Control . | Total . |
|---|---|---|---|
| N | 1712 | 8174 | 9866 |
| Median age at sample (range), y | 72 (41-98) | 65 (40-101) | 66 (40-101) |
| Male | 865 (50.5) | 2981 (36.1) | 3846 (38.9) |
| Race | |||
| White/non-Hispanic | 1630 (95.3) | 7772 (95.1) | 9402 (95.1) |
| Asian | 11 (0.6) | 72 (0.9) | 83 (0.8) |
| African American | 1 (0.1) | 35 (0.4) | 36 (0.4) |
| Other | 69 (4.0) | 295 (3.6) | 364 (3.7) |
| High count MBL | 93 (5.4) | — | — |
| >1 MBL immunophenotype | 85 (5.0) | — | — |
| Median hemoglobin (range), g/dL | N = 1249 | N = 5554 | |
| 13.9 (7.3-17.9) | 13.7 (4.8-19.3) | ||
| Median platelet count (range), ×109/L | N = 1248 | N = 5547 | |
| 220 (23-512) | 231 (45-871) | ||
| Median white blood count (range), ×109/L | N = 1247 | N = 5547 | |
| 6.4 (2.3-28.2) | 6.2 (1.8-22.5) | ||
| Median absolute lymphocyte count (range), ×109/L | N = 1126 | N = 4923 | |
| 1.6 (0.2-11.1) | 1.6 (0.1-7.9) |
| . | MBL . | Control . | Total . |
|---|---|---|---|
| N | 1712 | 8174 | 9866 |
| Median age at sample (range), y | 72 (41-98) | 65 (40-101) | 66 (40-101) |
| Male | 865 (50.5) | 2981 (36.1) | 3846 (38.9) |
| Race | |||
| White/non-Hispanic | 1630 (95.3) | 7772 (95.1) | 9402 (95.1) |
| Asian | 11 (0.6) | 72 (0.9) | 83 (0.8) |
| African American | 1 (0.1) | 35 (0.4) | 36 (0.4) |
| Other | 69 (4.0) | 295 (3.6) | 364 (3.7) |
| High count MBL | 93 (5.4) | — | — |
| >1 MBL immunophenotype | 85 (5.0) | — | — |
| Median hemoglobin (range), g/dL | N = 1249 | N = 5554 | |
| 13.9 (7.3-17.9) | 13.7 (4.8-19.3) | ||
| Median platelet count (range), ×109/L | N = 1248 | N = 5547 | |
| 220 (23-512) | 231 (45-871) | ||
| Median white blood count (range), ×109/L | N = 1247 | N = 5547 | |
| 6.4 (2.3-28.2) | 6.2 (1.8-22.5) | ||
| Median absolute lymphocyte count (range), ×109/L | N = 1126 | N = 4923 | |
| 1.6 (0.2-11.1) | 1.6 (0.1-7.9) |
Values are n (%) unless otherwise stated.